>> adobe. >> does it hold at the 81.5 level or does it open on change. that is what i'm watching sister. >> i'm melissa lee. thank you for watching. see you back here tomorrow at 5:00 for more "fast money." don't go >> my mission is simple. to make you money. i'm here to level the playing field for all investors. there's always a bull market somewhere. and i promise to help you find it. "mad money" starts now. >> hey i'm cramer. welcome to "mad money." welcome to crameria. other people want to make friends. i'm trying to make you money. my job is not just to entertain but educate and teach. so call me or tweet m me @jimcramer. be nice. as the hatred of the drug stocks finally meets the point where it can bring down the whole stock

market after today's action with the dow advancing just 14 points but s&p declining .36% and the nasdaq lost .65% i have to believe that it has. there's in sectors that matter to a market. sectors that can take down everything if their declines are owned enough. we have seen the banks hit the whole market. we have seen tech take down everything. no surprise, the second largest group of the s&p. we witnessed the industrials sandblast the market. even as they're often just plays on china. when china's economy is strong they do well and weak they do terribly. it makes sense as too many industrial hearsay their numbers cut because of china concerns and caterpillar has been hurt at tiles by weakness in europe too. the dow is filled with

industrials that have done better at this moment. hence why it went up. although a lot came from the expectations of dupont after the sudden departure of ceo ellen kullman. more on that later. but this knockdown in health care has taken my breath away and the wind out of the sales of much of the market because it shows you one of the great leaders of this period, progress has become the worst performing sector behaving almost as poorly as the oil stocks in the recent belly flops and that is one negative comparison. worse the illness in this group is no longer restricted to the highest growth members. in short, bio tech is now infecting everything. there is no quarentine. in truth you know from watching the show the big downturn started when many of the development stage biotechs began to get poppy.

that's a combination of underwriting fatigues and the most speculative portion of the group with no earnings, no dividends, no buy backs. but a exec bragged on cnbc that he was putting through gigantic price increases. we know there are drugs that cost a lot of money and are produced for small groups of people suffering from rare diseases. the class we call orphan drugs. they're often alternatives to fatalities or a form of lifetime maintenance that it makes the highest price drugs look like bargain. however this has now brought a level of political wrath that spread from the countries that raised prices on old drugs to

companies that spent fortunes to produce new drugs and raised prices consistently. now all drug companies include manage that have never been figured for political price gouging. hillary clinton is spear heading the drop. your slashing billions while raising prices. she is using criticisms. it's working. so is the challenge for real? is it lasting? will these drug companies not be able to put through these planned price increases? i think there will be some companies that won't be able to pass mark ups but really we're in a when the smoke clears situation. the problem is the smoke is not only still burning in our eyes it's spreading to other portions of the health care economy. companies like drug wholesalers where the hmos and hospitals all are trying to keep the cost

down. yeah, they're even crushing the drugstore operators despite the fact that they're for saving for the system money and omg, they're even smashing bristol-myers. to be sure there are real negatives here. last time we caught a short fall from a company that makes gene sequences equipment. you can argue that the weak orders in europe for its he equipment could be extending to a weakness in bio tech but have to tell you that's a stretch. in this market, though, they morphed into that. taking apart sector after sector. it's using any excuse to take the hammer down on bio tech. endless price increases from biogen, especially as it came right on the heels of a very negative new york times piece. price increases coupled with the slash of research and

development. we also got a rude awakening from exact sciences. something called the u.s. services task force. the stock lost half it's value. it's now down 46% in one day. many thought the exact sciences test which allows doctors to make a judgment by looking at your excrement instead of the col col colonoscopy would be better. but that's smacking of a little bit of absurdity to me. this selling is way overdone. it smacks of wholesalely inquiriati -- wholesale liquidation. the highest growth stocks trade together. that's why we could see a spill over in chipotle. a loss by sour numbers from yum

brands this evening or in the most robust portion like avago or sky works solution. being a total travesty given that it told us it was paying $2 billion. a tech, storage and optical company which will broaden it's reach into the enterprises. i thought it made a lot of sense. adobe's disappointing objections shocked me since they just announced not only ago can only prolong the agony. instead the money is falling into the lowest stocks in old tech. cisco and hewlett-packard. this move has been picking up steam since western digital caught a buyer and micron failed to go down after one more disappointing quarter. i have long held on this show and this is the 11th year, i have said over and over again that actual growth, real growth is the magic elixur behind the

best stocks but i have also seen them swoon particularly after big runs. this is part of the equation. it has happened and just always happens. the growth stocks get big and then they get pull backs. sometimes it's self-fulfilling as in the overwhelming deals that sopped up excess cash and there's more in the price. this rotation has some of the characteristics. sometimes it's part of a larger redemption run against money managers whose only stocks need to raise cash and sometimes it's because the charts are just plain ugly. this is being driven by all four of these factors and believe me no politician is going to stop. it's just too easy to demonize

the drug stocks. that's it. let's accept it. but nothing more. it doesn't mean you'll make money if you start buying health care right here. you might be on board. but the stocks get to levels that are cheap versus their growth rates and you have to act. in some cases. believe it or not, i think we're really close. if not there already. jim in michigan, jim. >> booyah cramer. >> what's up, chief. >> good. terrific. i watch your show every chance i

get. >> thank you. >> my question is about a company for dialysis patients. some analysts have a $26 price target on it. my question and thoughts are for you about rockwell medical. >> see now this is a tough one. morgan stanley has a sell on it. we have all of these great companies. i mean, look, let me put it this way to you. let's say you bump into me on the street and you say i want rockwell medical, i will say all right, celgene was it 140. it went to 83. it's moved up and down and it's at 112. i prefer you to buy 25 shares of celgene and down 10 another 25. i would feel much more comfortable when we bumped into each other again and i think you say thank you for celgene. you might say rockwell medical. what were you thinking. let's go to cliff in new york.

>> good evening. i am a long time viewer and first time caller. i purchased milan on your wise council. it has taken it's hostile bid to shareholders. i was wondering how you would vote had you owned the stock. >> i would vote. this stock would be much higher without that bid. this is so much like what happened to air gas when he said if air products walks away this stock would soar and then the stock went up about 50%. if just if mylan would just go away then joe can work his magic and they would go much higher. all right. we have reached the point where health care stocks can now take down the whole market and boy they did today. some of these are too low to ignore and you have to start doing the homework or think about pulling the trigger. on mad tonight, the september

sell off caused many groups to lose their luster. i'm adding one more sector to the list. then playing the numbers game? i'm analyzing the contrast between pepsico and duponts latest earnings. the technicals are pointing to two stocks you aren't thinking about. i'll reveal these tech turnarounds just ahead. so stick with cramer. >> don't miss a second of "mad money." follow @jim cramer on twitter. have a question? tweet cramer, #madtweets. send jim an e-mail to madmoney@cnbc.com or give us a call at 1-800-743-cnbc. miss something? head to madmoney.cnbc.com.

as i said at the top of the show, the brutal selling that gab in august and september continues to send some of the markets most beloved groups spiraling lower from the bio techs to the roll ups to virtually anything that can be construed as a growth stock at

this point in the endlessly morphing bear of a tape. but some of the worst carnage hit the worst out there. the cyber security group. this has gone from the most loved and pretty much the most loved for the last year. one of the most hated. it's done it in record time. the only etf out there, down 23% from its late june all time high and that's just the etf. several individual cyber security stocks have fallen even further. so much so, you know what, i'm wondering if it might just be tile for investors to start circling back to this group and picket some of their favorite names all at significant discounts to where they were a couple of months ago. that's right. i think it's possible that the once high flying cyber security stocks might represent some value even as they're still expensive on an earnings basis. these companies have tremendous

growth over multiple years. you think about it over multiple days. you're not going to make money and with the exception of a few lower quality names nothing has changed except for that the whole area is going out of style. remember all things growth have been obliterated during the last couple of months and in particular high flying stocks with no dividends and little in the way of earnings they have really been hammered but there's a third factor that's specific to the cyber security place. the fact that they're also heavily correlated with this etf. it caused the cyber security funds to move down and more than other areas where there tend to be multiple different etfs so when one company in the sector stumbles the negative pinks is horrendous. it's as brutal as can be. the money cascades out of the etf and all the stock is sold down. we have a textbook example of this today.

a company called rad wear. it slashed it's third quarter guidance. it saw it's stock plunge 20%. says they represent 3.5% of the hac etf no surprise they dropped nearly 3% today. put it all together and many of the stocks could actually be relevant bargains. that's important. these stocks are expensive but relative bargains versus where they have been. why don't we just tick down. not recommending them but trying to get this in your face that this group is for sale. i'm not pounding the table. remember for ages the stocks were way too pricey. it's only natural. first there's palo alto

networks. i liked it for a long time. it's down 13% from this late july highs. although in late august you could have gotten to the mid 150s and we're looking for that to happen if we get a retest. not calling the bottom here. the thing is that unlike many of its competitors it is profitable. right here, right now and the stock has gotten relatively cheaper as it's going lower. back in july it traded as high as 123 times forward earnings. that's the most expensive stock i follow and while the stock is priced at these levels it's less expensive at 90 times earnings. but that may sound like a valuation but you have to remember that palo alto networks has the fastest growth of any company that's profitable that i follow. you're not going to get this thing anywhere near a market multiple. you're stuck having to overpay for the fastest growing company.

has the narrative changed? not really. if anything it's gotten better. also giving stronger than expected guidance. in other words we know they continue to do well here which means that when the stock goes lower like today it's more of bargain. you know what, if you had to start buying one maybe you start doing this one. how about fireye. that's what companies bring in after they get sacked. down 44% from his june highs. because the company is still unprofitable it's harder to value something like that versus palo alto but it's trading at 12.6 times sales in june and now it's under 8 times sales and just like palo alto the most recent quarter report was quite bullish. top and bottom line beat. when you have that kind of growth you're not going to get

it at a market multiple. at the same time the company reported on july 30th and announced the departure of the cfo. still fireeye brought in a replacement cfo from a good company a month ago and the stock has been punished enough. it's worth pointing out that it was downgraded from overweight to neutral and with the analysts that like the stock all the way down suddenly getting more negative, maybe want to start thinking about taking the other side of the trade, the stocks come down quite a deal. it was once the hottest of the hot. israeli cyber security company helps businesses protect what are known as the key or privileged accounts. basically the keys to the entire digital kingdom. the stock plummeted down to the 52 level although you could have put it in the high 40s. at its peak trading 120 times earnings. still expensive in absolute

terms but we judge stocks on a relative basis when you get this high kind of growth. cyberark is for of bargain. plus the company reported a huge beat on august 11th much higher than expected sales in earnings up to the next quarter. however despite those results stocks sold 6.7% the next day. part because people realized great numbers couldn't send the cyber security stocks higher in such a difficult market. since then a bunch of analysts upgraded cyberark and stocks continue to go lower. finally, let's not forget about my favorite cyber security play and the only one that my charitable trust owns, cisco. the networking titan with a rapidly growing security business. it is still down 10% this past march although it reported a terrific quarter. plus cisco trades at 11 times earnings. what is that about? it has a 3% yield.

are you kidding me? here's the bottom line. the whole cyber security group has been related lower over the past two months. and while nobody would ever call these stocks cheap they're a lot less expensive than they were not long ago. you looking for a little higher risk that's fireye or cyberark and as long as you recognize they're for long-term consumption only i bless it. some of these names are too difficult to trade in equity form. i would use, as i said in get back to even i would use deep in the money calls. that's the way you would play with these stocks in order to cutoff your down side while magnifying your upside. or if you want a cyber security play i think is safe, do what i'm doing with my charitable trust. stick with cisco. much more "mad money" ahead including the power of peltz.

how he lead to one big winner and one big loser in the market. i'm going off the charts. why creativity isn't key when it comes to make money. plus i have a company prepared to change and even effect it. stick with cramer.

the numbers, it all comes down to the numbers. it always comes down to the numbers. pepsico just delivered spectacular numbers this morning. but kullman produced hideous results last night. the result? kullman is out. sure dupont is a chemical company and pepsico sells snacks and sodas but they have one big thing in common. the activist fund run by nelson peltz tried to effect things of both companies. he's the only one i can find where you can beat the averages by piggy backing off of his investments after he announces it and not before. but they responded in vastly different ways. rather than getting in a prolonged and distracting fight with peltz they showed him with the combination of snacks and

beverages can be a winning one. he wanted to break up the company to have separate entities. in the meantime, it's allowed him to deliver results like this morning including double digit gains in gatorade by the way and fabulous pricing for snacks and improved quaker division and wildly expanding gross margins. a winner can keep any critic at bay and he's a winner. kullman, though, that whole battle was a needless waste of time and resources. peltz has a huge position in dupont and one said the company break up to unlock real value. that's reasonable to me. he's a tremendous business person that knows dupont better than anybody else. peltz wasn't after kullman's head. he just wanted to be a change agent. they said no way to a board seat for the man. the possibility that trying suggestions could be enacted sent this stock soaring but when he failed to win mostly because

big index funds voted with somethingment something that's curious in their own right because they checked their brains at the door, the stock plummeted. dupont's numbers have been lousy which is why they folded nearly 7% after kullman re-signed and they pointed her successor on an interim basis. kullman was viewed in standing in the way of a break up but she promised better results than delivered and this was the latest in a series of big bind downs. breen created tremendous value with tyco and hope is he will do the same with dupont. she spun off the most commoditzed part of the company. something that peltz predicted to me would happen was the last straw as the board recognized

that someone else could do a better job at pepsico you see the opposite happening. many are concerned about the slowing of droft sink sales. it declined down 2% for regular and 6% this revenue alone. even more important, snacks are such a powerful story they can make up for any prolonged short fall in the soda business. in the end she wins because she put up the numbers and kullman loses because she didn't. maybe if kullman hadn't been so stubborn there might have been a different more positive outcome for both her and dupont shareholders. paul in connecticut, please, paul. >> booyah cramer. >> booyah, paul. >> in connecticut we love our dunkin donuts coffee and with the announcement of the weaker sales growth in the 3rd quarter and 100 locations between 2016

is this a time to sale? >> this stock has nine lives but the company doesn't. i was disappointed. i think that you should exit duncan. i was just really disappointed. it took my breath away. i'm not going to back it in anyway, shape, or form. nick in illinois, nick. >> hey, jim, this is rick in chicago. how are you? >> fine, how are you? >> great. love your show. g go cubs. >> all right. we'll go cubs. >> i have a question for you. i own about a thousand shares of huntsman in the past year i think it's dropped probably by 60% from its high and i was wondering if i should keep it. >> i don't know why you would own it. it's just rallied back to existence. it had a terrible quarter.

my charitable trust owns dow chemical. i have no edge on why you want to own other than the fact that it is 11 and it used to be higher. that's not good enough anymore. it's all about the numbers baby and the contest couldn't be any greater. who now is the best in class exec. i'm identifying the companies and what's driving them higher. then the affordable care act is expanding to millions of americans and that's running a big prescription to hospitals across the country. can they help you play the trend? i got the exclusive with the ceo and your calls in today's edition of the lightning round. stick with cramer.

just when the most expensive highest growth stocks in this market are rolling over and they're doing that big time, guess what's flying? how about one of the cheapest and slowest growing sectors out there? what i call old tech. after weeks of turmoil we cannot only spot the stocks that money is flying at them but we can see where the money is flowing into and old tech has been providing new but uncertain leadership in this period. is it real or fleeting? we're going off the charts with brilliant technician and founder and senior strategist at explosive options.net. in order to identify these new new tech leaders, new old tech leaders, old new tech leaders. whatever, see if the performance can continue. he points out you don't need to get creative. you just need to reach for

boring old line tech names that are rising from the ashes even as the other stuff is getting pasted. after the averages were hurt badly back in august there were some stocks that managed to rebound quite nicely. nobody wanted to buy anything during that carnage though. then they retested their lows at one point last week and a number of stocks bottomed at august and kept going higher since then. interesting. two of the big ones are very familiar. intel and microsoft. they have been the best performers in the index since august 24th. since then, microsoft rallied 12%. inobstetrical is 20% higher. these are invisible. it's tough to imagine these moving up so much but when you look at their charts you can understand what's propelling them higher. tech check. i think i shopped at tech check. i bought lifesavers there. no that's quick check. let's take a look at microsoft's

daily chart. how do we explain the out performance over the last six weeks? first check, the money flow, that's down at the bottom of the chart. this is the 21 day average of the accumulation distribution line. that means it measures the level of buying or selling pressure in stock. they use it to get a sense of whether the big institution money managers are buying or selling. let's just see it ahead of time and the indicator barely dipped into negative territory. this is really incredible. barely dipped in august and in recent weeks, look how positive this thing is and that's a lot for a stock in a market that's been really bad. meanwhile, since the big bottom, they are made higher highs and higher lows. the rest of the market has been absolutely mag fnificentmagnifi.

200 day, 50, see that trading above and shorter term 50-day moving average is still above the longer term 200 day moving average which tells them the trajectory is very positive. you have the blue above the red. plus volume trends have been very strong of late. that's volume okay. with people doing a lot of buying on up days and that keeps pushing the stock higher. on top of all of that, microsoft is now -- this is a new one, in a rare fat tail zone meaning it's seen at a price trading 5% of the time. microsoft has broken out from the area where you expect it and is now rallying like crazy. there's tremendous price acceleration. he is saying forget it. just beginning. in fact right now microsoft is only 7% away from its high of just over $50.

la langley's investors are climbing into these. next up how about the daily chart of intel? remember when they disappointed people fleeing the stock? guess what, after lackluster performance early in the year as we can see, all right, down, down, down, the stock absolutely exploded higher. lang says that intel performed tremendously even as it managed to stay on the radar. is anyone talking about intel? it's been rallying. it helped support many of the older semi-conductor names. when you look at the moving average or the mac d an important momentum indicator used in the stocks trajectory you can see that it made a bullish cross over. right where i sneezed it made a bullish cross over where the black line goes above the red one. that's what made me sneeze. right near the end of september. historically speaking that cross over is basically screaming buy

inobstetrical. and now we go back to the cmf, that's when we looked at microsoft. in the case of inobstetrical this has been negative territory since june. okay. this is the cmf. negative, negative, negative and then right here. last few weeks is going positive. the big boys are just now piling in to those that think they missed it. it's just happening now. plus inobstetrical's volume trends have been positive since september started. we have some nice addition in volume so that's a good sign too. it's rallying on big volume. it's not a fluke. but best of all, inobstetrical has a powerful, here we go, inverse head and shoulders pattern. it's one of the most reliable ones in the book.

and then you have two smaller declines. intel has just now crossed the neckline. that's what you want to see, it tells you that the head and shoulders formation is for real. based on this, he thinks it can travel from 31 and change up to 35 in a pretty short period of time. that would be a show stopper. it's represented by the blue line and still below that day. microsoft was the other way. but lang thinks that might change giving you the moving average cross over. one final point when it comes to intel. we don't know how it's going to be. so if you want to buy intel i suggest putting on a little bit of your position before reports. get some weakness before the earnings report. maybe that terrible number of projections that adobe made tonight and waiting until the quarter to buy the rest.

here's the bottom line. yes, this market can be difficult. it can be treacherous but the charts show that intel and microsoft can keep roaring and these are exactly the kinds of stocks you might want to buy. low multiple stocks if we get another big downdraft or maybe even if we don't. "mad money" will be back after the break.

it is time, it is time for the lightning round. and then the lightning round is over. are you ready? time for the lightning round. we'll start with chris in new york. chris. >> linn energy, buy, hold or sell. >> they just extended their distribution. so. sell. it's like the hook there. how about nick in texas. >> booyah cramer. my question is on teledot. >> yeah, they lost that contact.

that was uninspiring and i think you have to keep doing some work on that one. dirk in texas. >> hey, jim. a great big go astros to you. >> yeah, man. that's terrific. >> listen i want to know what you think about our utility infrastructure company. center point energy. >> i think it's too low. at 5.35%, i think that's a buy. i think that stock is down too low. i like that idea. don in florida please, don. >> yes, jim, booyah. my stock is blackstone group. >> people have been comparing it unfavorably to jacksonville and unfavorably to tampa bay, those are all wrong. it's a whenneinner, not a loser. it should be bought. jerry in florida. >> thank you for taking my call mr. cramer. my call is about cvs health.

it seems that cvs health has its hands in almost every aspect of the health industry and now it's in the process of opening up optical and hearing aid centers. >> i like cvs. i know that the chart is terrible but i think you start buying cvs right here. buy it 2592 and you'll have a great position over multiple years time. let's go to sean in massachusetts. >> sean from massachusetts, jim. >> hey. >> should i buy more transocean rig? >> transocean is probably done going down. if that's the case i would buy

slumber. why don't we take one more. let's go to sammy in california. >> hey, jim, what do you think of seagate technology? >> it's cheap. i like the deal that western digital did selling 15% of the company. that makes me want to own seagate. that's working. that ladies and gentlemen is the conclusion of the lightning round. >> the lightning round is sponsored by t.d. ameritrade. random? no it's all about understanding patterns like the mail guy at 3:12 every day or jerry, getting dumped every third tuesday. this happens every third tuesday. we have pattern recognition technology on any chart, plus over 300 customizable studies to help you anticipate potential price movement. there's no way to predict that. for all the confidence you need. td ameritrade. you got this.

we figure you probably don't have time to wait on hold. that's why at xfinity we're hard at work,

building new apps like this one that lets you choose a time for us to call you. so instead of waiting on hold, we'll call you when things are just as wonderful... [phone ringing] but a little less crazy. we're doing everything we can to give you the best experience possible. because we should fit into your life. not the other way around.

is this sell off related to drug stocks obscuring the strength in high quality health companies? it has nothing to do with drug prices. i think the rollover in the health care space is getting ridiculous. take premiere. it's the company that allows doctors and hospitals to save money on medical supplies also helping them improve the quality of their care and produce better patient outcomes. more than 3,600 hospitals and 120,000 alternative care sites nationwide. they use the collective purchasing power of all it's clients to help them get drugs and awe plies at lower prices. plus it has the data and analytics where they help make cost and quality improvements. if anything premiere light benefit if the politicians in washington push down the cost of

high priced drugs. plus a strong quarter last august and the company raised it's full year revenue guidance. you expect them to go up on that news and not down. we'll learn more about how the company is doing and where it's headin heading. welcome to mad money. >> just because the market is so nutty you raised guidance and had a big contract from the government and that allowed you to raise guidance. >> that's right. we're trying to solve the problems you discussed. problems from patients and health care systems around the high cost of pharmaceuticals and supplies and improving the quality and safety. raises the price of the drug 5,000%. >> yeah, we do check that every day. >> there's the friction between companies and we actually have that that runs through our

repurchasing organization and we're able to bring clinical information together with pricing information to figure out what is appropriate. >> how perfect is the market or does the market your help because there's so many anomalies. >> the market needs our help a lot. it's a combination of this fragmented system that needs to improve quality, improve safety and lower the cost of the inputs, the supplies. >> when we see, for instance, we had a bunch of really good-bye owe tech companies come in but they talk about pricing it seems a little bit absurd. what do you do? do you go in to them and say look we've got all these different buyers we're not paying that retail price? >> what we do is we bring competitor suppliers in and we have them and we negotiate contracts with them for the lowest possible price. our members stand behind that. we support the use of generics and biosimms and then we help

figure out how much of a drug they're using and should they be using it to begin with? does it change the clinical outcomes? so we're able to bring all of that to bear in the end decision around a contract price. >> if someone isn't part of your network when you go in to sell a big network what kind of savings can you show them? >> we have a big system in ohio. mercy health system. 450 health care locations. we have saved them over the last four years $120 million and we're able to do that by corralling all of their volume, buying together with other health systems and then helping them improve their clinical effectiveness. >> we're getting hesitant when we see a lot of acquisition. what do these do and why does it make sense and why should we not fear that you're doing a roll up when there's so many acquisitions to keep track of them. >> we've been around a long time. when i wake up i think 120

patients out there. we have a 40 million -- >> 120 million? >> one third of the country. >> 40% footprint which means we have the opportunity to impact the health care of 120 million people. and that is a big obligation and for me this is a calling. this is i'm trying to transform the health care system together with providers from the inside. i don't think government can fix this by itself. i don't think insurers can fix this. i think that people delivering care together with patients having all of the data, all of the infrastructure, all of the collaboration with solve this problem. >> i'm glad i had you on because a lot of people are thinking who can stand in the way of these companies that just raise price, raise price, raise price. >> we have company contracts and contracts with suppliers and it takes all of them to solve this problem. >> that's the president and ceo of premiere. new company for us. a lot of information about it.

you can find out much more for a company solving problems and not adding to our problems for health care. stick with cramer. it's what sparks ideas. moves the world forward. invest with those who see the world as unstoppable. who have the curiosity to look beyond the expected and the conviction to be in it for the long term. oppenheimerfunds believes that's the right way to invest... ...in this big, bold, beautiful world.

one take away from the show, there is some value in health care. so don't throw them all away. i like to say there's always a bull market somewhere. promise to try to find it just for you right here on "mad money." i'm jim cramer. see you tomorrow. lemonis: tonight on "the profit,"

i head to south carolina to get a real taste of good old-fashioned barbecue. norton: if the fat ain't dripping on the coals, it's not barbecue. lemonis: a mom-and-pop operation has quickly grown into a million-dollar business. you're almost doing $1 million a year. you guys aren't mom-and-pop anymore. they are struggling to keep up. norton: we've grown faster than we ever imagined we would grow. we have not caught up with ourselves. lynn: this is overwhelming. lemonis: authentic, down-home cooking never goes out of style. lynn: mom always taught us, whatever we do, we do at our best. lemonis: if i can stabilize this business... we're not charging enough. ...there's big money to be made. this meal was amazing. these ribs are ridiculous. my name is marcus lemonis, and i fix failing businesses. if you don't like money, don't follow my advice.